...
首页> 外文期刊>Clinical and experimental ophthalmology >Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides.
【24h】

Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides.

机译:不同的睫状肌麻痹剂对儿童黑色色素的安全性和疗效的比较研究。

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background: The ideal cycloplegic drug that is safe, effective and convenient in children is not yet available. This study aimed to evaluate the safety and efficacy of three cycloplegic regimens in hyperopic children with pigmented irides. The responses to cycloplegia in different age groups and presence of strabismus were also compared. Methods: Tropicamide 0.5% and phenylephrine 0.5% (regimen I), tropicamide 1.0% and cyclopentolate 1.0% (regimen II), and atropine 1.0% (regimen III) were evaluated in 25 children using a crossover study design. Cycloplegic refractions were assessed. Results: The mean age of the children was 5.7 +/- 2.0 years (range 2.5-10.8 years). Six (24.0%) of them had strabismus. The spherical equivalent (SE) refraction for regimens I, II and III were +5.11 +/- 2.04 D, +5.29 +/- 1.89 D and +5.71 +/- 1.90 D, respectively, and were significant different from the manifest SE (+3.95 +/- 2.17 D) (P < 0.001). There was no statistical difference between regimen I and II in children without strabismus (P = 0.258) or aged older than 5 years (P > 0.050). Conclusion: In older children, regimen I was as effective as regimen II and can be used to avoid cyclopentolate toxicity.
机译:摘要背景:目前尚无一种理想的安全,有效,方便的小儿麻痹药物。这项研究的目的是评估在患有虹彩色素的远视儿童中三种睫状肌麻痹方案的安全性和有效性。还比较了不同年龄组对斜视的反应以及斜视的存在。方法:采用交叉研究设计,对25名儿童进行了0.5%的托吡卡胺和0.5%的去氧肾上腺素(方案I),托品酰胺1.0%和环戊酸酯1.0%(方案II)和阿托品1.0%(方案III)的评估。评估了腿痛的屈光度。结果:儿童的平均年龄为5.7 +/- 2.0岁(范围2.5-10.8岁)。其中六名(24.0%)患有斜视。方法I,II和III的等效球面(SE)屈光度分别为+5.11 +/- 2.04 D,+ 5.29 +/- 1.89 D和+5.71 +/- 1.90 D,与清单SE显着不同( +3.95 +/- 2.17 D)(P <0.001)。没有斜视的儿童(P = 0.258)或5岁以上的儿童(P> 0.050),方案I和方案II之间没有统计学差异。结论:对于年龄较大的儿童,方案I与方案II一样有效,可用于避免环戊酸酯毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号